Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis.

Purpose Tyrosine kinase inhibitors (TKIs) are the cornerstones of treatment for patients with chronic myeloid leukaemia (CML). In recent years, several studies were conducted to evaluate the safety of TKIs discontinuation. We performed a systematic review of the literature to determine the incidence...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Cancer Vol. 77; pp. 48 - 57
Autores principales:	Campiotti, Leonardo, Suter, Matteo Basilio, Guasti, Luigina, Piazza, Rocco, Gambacorti-Passerini, Carlo, Grandi, Anna Maria, Squizzato, Alessandro
Formato:	meta analysis research systematic review Journal Article
Publicado:	Pergamon Press - An Imprint of Elsevier Science May2017
Acceso en línea:	Ver este registro en EBSCOhost